CAS 1300037-86-8

Tapentadol O-β-D-glucuronide

CAS: 1300037-86-8

Ref: 7W-GC1337

Tapentadol O-b-D-Glucuronide

Produto Controlado

CAS: 1300037-86-8

Applications A metabolite of Tapentadol (T007200).
References Terlinden, R., et al.: Eur. J. Drug Metab. Pharmacokinet., 32, 163 (2007), Tzschentke, T., et al.: J. Pharmacol. Exp. Ther., 323, 256 (2007), Wade, W., et al.: Clin. Ther., 31, 2804 (2009),

Fórmula: C₂₀H₃₁NO₇

Cor e Forma: Neat

Peso molecular: 397.46

Ref: TR-T007210

Tapentadol O-b-D-Glucuronide (1 mg/ml in Methanol)

Produto Controlado

CAS: 1300037-86-8

Fórmula: C₂₀H₃₁NO₇

Cor e Forma: Colourless

Peso molecular: 397.46

Ref: TR-KIT0155

Tapentadol-d5 O-β-D-Glucuronide

Produto Controlado

CAS: 1300037-86-8

Fórmula: C₂₀D₅H₂₆NO₇

Cor e Forma: Neat

Peso molecular: 402.493

Ref: TR-T007212

Tapentadol-²-D-glucuronide solution

Produto Controlado

CAS: 1300037-86-8

Tapentadol is a centrally acting analgesic agent that binds to the µ-opioid receptor. Tapentadol is metabolized in the liver by glucuronidation and sulfation. Tapentadol 2-D-glucuronide is an active metabolite of tapentadol and exhibits a higher affinity for µ-opioid receptors than tapentadol. The clinical relevance of this metabolite has not been studied, but concentrations of tapentadol 2-D-glucuronide in plasma may be useful for monitoring therapeutic effects and for assessing side effects such as respiratory depression. It is believed that tapentadol 2-D-glucuronide binds to opioid receptors in the brain, spinal cord, and peripheral nervous system, which accounts for its analgesic properties. The clinical development of tapentadol was designed to assess its safety and efficacy in pediatric patients (ages 6–17 years). Plasma concentrations were measured using liquid chromatography

Fórmula: C₂₀H₃₁NO₇

Pureza: Min. 95%

Peso molecular: 397.46 g/mol

Ref: 3D-ACC03786